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 The overall focus of this project has two parts:  First, was to develop a protocol utilizing 
serum-free media formulations and defined plating and culture techniques to create functional in 
vitro myotubes derived from adult skeletal muscle satellite cells.  The second was to manipulate 
the inherent muscle parameters such as force output and fatigue of these myotubes by employing 
exercise regimes or by small molecule application.   
 The importance of serum-free medium use for in vitro cultures is becoming increasingly 
important in creating functional systems that can be validated for drug testing by the Food and 
Drug Administration (FDA).  Also, the study of age related diseases as well as the potential for 
“personalized medicine” relies on the proliferation and maturation of satellite cells from adult 
derived tissue.  For that purpose, a serum-free medium and culture system was designed to create 
mature striated myotubes in culture on a defined non-biological substrate N-1[3-trimethoxysilyl 
propyl] diethylenetriamine (DETA). These myotubes were evaluated by morphology, muscle 
specific protein expression, and by muscle functionality.  After the thorough characterization of 
the resultant myotubes the functional output of the muscle was altered utilizing chemical means 
(creatine supplementation and PGC-1α agonists), chronic long term stimulation, and the use of 
PGC-1α deficient tissue.   
 In this thesis presentation the utility of the newly developed medium formulation to 
create myotubes from a variety of adult derived muscle sources will be shown.  A protocol in 
which to exercise skeletal muscle in vitro to alter endurance was developed and employed to 
manipulate skeletal muscle.  Finally, small molecules were tested to validate this system for drug 
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study use.  This engineered system has the potential for high-throughput screening of drugs for 
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CHAPTER ONE: INTRODUCTION 
 Skeletal muscle tissue engineering is an interdisciplinary field that incorporates cell 
biology and engineering to recapitulate fusion of individual mononucleated cells to generate 
functional multinucleated muscle.  In vivo biological muscle involves a complex interaction 
between 3 main components: cells, extracellular matrix (ECM)( that consists of an array of 
proteoglycans, proteins, and glycosaminoglycans) and finally, signaling factors (Figure 1).[1]  In 
vitro skeletal muscle engineering focuses on utilizing these three main components to 
recapitulate functional muscle for a variety of purposes including but not limited to grafting and 
drug discovery. Since the “origin” of skeletal muscle engineering in the 1970’s [2-4] there have 
been considerable advancements in all three aspects of this field. 
 The original sources of progenitor cells were derived from the fetal tissue, typically of 
rodents or chick origin.[5-7] Typically the pectoral muscle or the hind limbs would be dissected 
and processed to release embryonic myoblasts that would be expanded and eventually fused to 
form myotubes or myofibers.  This requires pregnancy of the maternal species as well as 
sacrifice to mother and offspring.  While this provided a generous progenitor cell population that 
had relative ease of culturing in vitro, it had limitations.  The cell source population has now 
expanded to include adult tissue derived skeletal muscle that provides ease of dissection and is 
more applicable to age related diseases.[8, 9]  As well as, stem cells, both embryonic derived and 
induced pluripotent, which possess little to no invasive properties and also immortalized cell 
lines.[10-12]  This thesis will focus on adult derived satellite cell skeletal muscle engineering. 
The first medium formulations consisted of a simple base medium subsidized with a 
range of sera derived from prenatal animals, most commonly from fetal bovine subjects, ranging 
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from a concentration of 10-30% volume/volume.  When these expanding cells have reached 
confluency a complete withdraw or minimalized withdraw of medium supplemented with low 
levels of horse or donkey serum resulted in myoblast fusion.[13-15]  Since these initial 
formulations were introduced onto the biomedical scene there have been integral advancements 
in media compositions that further the in vitro myoblast fusion and maturation.  For the future of 
drug development processes and drug discovery systems a defined serum free medium 
formulation system capable of being unbiased analyzed and interrogated is necessary to adhere 
to NIH and FDA initiatives and will be discussed further in this thesis.  
 In vivo skeletal muscle consists of muscle tissue, tendons, connective tissue, blood 
vessels and nerves. A connective tissue known as the epimysium surrounds the whole muscle.  
The whole muscle is composed of bundles of fibers known as fasciculi and are surrounded by a 
sublayer of connective tissue, the perimysium.  Further investigation elucidates that each  
fasciculi consists of individual fibers surrounded by more connective tissue called endomysium.  
Each individual fiber consists hundreds or thousands of individual components known as 
myofibrils that make up the actual contractile functionality of skeletal muscle.  Skeletal muscle is 
typically known as striated muscle due to the light and dark bands seen by light microscope.  
This is caused by the very orderly arrangement of the myosin and actin filaments that compose 
the contractile machinery within the myofibril.  Single sarcomere consists of alternating actin 
and myosin filaments that allow for the Adenosine Tri-phosphate (ATP) motorhead located on 
the myosin filament to attach to actin filaments and provide contraction (Figure 2).  In in vitro 
muscle the formation of this highly complex arrangement is indicative of functionally mature 
myofibrils (or myotubes). 
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 Along with contractile machinery, myofibrils possess the same components as other cells, 
nuclei, enzymes, proteins, and mitochondria.  The inherent strength of muscle and it’s endurance  
are reliant on a few factors:[16-18] 
1. Myosin ATPase activity 
2. Succinic dehydrogenase (SDH) 
3. Mitochondrial content (oxidative capacity) 
Muscle with high ATPase activity and low mitochondria content and low SDH levels 
have rapid and forceful output but are rapidly fatigued (Type II fibers or fast-twitch). 
Conversely, muscle with low ATPase activity and high mitochondria content and high SDH 
levels possess less forceful and slower contraction but have high endurance levels (Type I fibers 
or slow-twitch). [16-18]  The SDH, mitochondria levels, and Myosin ATPase activity can all be 
altered both in vivo and in vitro by a variety of factors.  Exercise, both plyometric and endurance, 
can drive fiber conversion from slow to fast or vice versa as well as small molecule or drug 
applications that alter pathways responsible for mitochondria biogenesis or SDH production.[11, 
19-22] 
The development of an in vitro culture system  consisting of functionally mature 
myotubes derived from adult skeletal muscle myoblasts grown in serum-free conditions is of 
paramount importance.  Furthermore, the ability to measure contractile strength and endurance of 
this muscle provides a unique test bed for future drug discovery., The ability to measure changes 
to force and fatigue of muscle in response to exercise and drug application spawns a  promising 
avenue by which to study exercise physiology, drug efficacy and toxicity, and utilizing adult 




Figure 1: The tissue engineering paradigm 
Adapted from (Makris, E.A., et al., Repair and tissue engineering techniques for articular 





Figure 2: Muscle split into various components 







CHAPTER TWO: FUNCTIONAL MYOTUBE FORMATION FROM 
ADULT RAT SATELLITE CELLS IN A DEFINED SERUM-FREE 
MEDIUM 
Introduction 
 Adult tissue-derived in vitro systems provide a unique modality to study physiologic and 
age related diseases. The study of adult skeletal muscle physiology and myopathies has 
especially benefitted from the ease of isolation of satellite cells which are adult muscle 
progenitor cells. Satellite cells are situated between the sarcolemma and basal lamina of muscle 
fibers. These normally quiescent cells, activated in response to exercise and pathological injuries, 
migrate to the site of damage where they proliferate, elongate, and fuse to each other, as well as 
to existing myofibers, to replace lost or damaged cellular material [24]. 
Currently, the prevailing dogma for the study of muscle related diseases and 
physiological phenomenon in vitro focuses on cells derived from adult animals grown in serum-
containing medium formulations. Generally, animal-sera have been used in adult and embryonic 
muscle culture due to their ability to enable the rapid proliferation of muscle cells [13-15].  Once 
the cells have reached a confluent monolayer, the removal, or drastic reduction, of serum 
concentration triggers extensive myotube formation in the cultured cells. This has been the long 
established protocol due to cost efficiency, relative ease of use, and general effectiveness [25]. 
The drawback of this culture system is that the contents of animal sera have not been fully 
elucidated nor well characterized; there is also the batch to batch variability that occurs during 
serum production [26, 27]. Therefore, one cannot rule out the possibility of adverse stimulatory 
or inhibitory effects occurring as a result of its use. Consequently, the clinical applications of an 
in vitro model system that uses serum containing medium formulations are limited.    
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Previous work has detailed the development of a serum-free system that mimics the in 
vivo process of myotube formation and the physiological contractile properties of myotubes 
derived from fetal hind-limb satellite cells [28-30]. However, the use of embryonic muscle limits 
the applicability of these systems to the study of age related diseases and adult physiological 
processes such as Myosin Heavy Chain (MyHC) class switching.   
To address this issue a culture system was developed where all aspects of the system 
were defined and controlled to provide a new model for the study of adult muscle physiology and 
disease. The process utilized satellite cells derived from adult rat hind-limbs, a defined serum-
free media formulation, as well as a non-biological cell growth promoting substrate N-1[3-
trimethoxysilyl propyl] diethylenetriamine (DETA). The triamine functionality of DETA is also 
a structural analog to spermidine, a growth factor known to promote cellular survival [31, 32]. 
This system exhibited physiological maturation (adult MyHC expression) and responded to 
physiological stimuli to provide a suitable model for the study of age related disease and muscle 
myopathies. Combined with previous work modeling neuromuscular junction formation [33-36] 
new functional assays could be developed from the adult cells derived from transgenics or 
disease related animals for more relevant in vitro disease models. Recent FDA/NIH initiatives 
for regulatory science require the use of serum-free media and as such, a new serum-free system 
for the study of adult derived skeletal muscle myotubes will be of paramount importance in the 





Materials and Methods 
Surface Modification and Characterization 
 Glass coverslips (VWR cat. nr. 48366067, 22×22 mm
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 No. 1) arranged in ceramic 
staining racks (Thomas Scientific, Swedesboro, NJ) were chemically cleaned and dried prior to 
surface modification. First, the coverslips were soaked in a solution of 50/50 methanol (VWR 
cat. nr. BJLP230-4) / hydrochloric acid (VWR cat. nr. EM1.00314.2503) for 2 hours and then 
rinsed thoroughly with DI water. The coverslips were then immersed in concentrated sulfuric 
acid (VWR cat. nr. BDH3072) for a minimum of 2 hours, rinsed as before and then boiled in 
deionized water for at least 30 minutes. After boiling the glass slides were placed in an oven set 
to 110°C and allowed to dry overnight. The 3-Trimethoxysilyl propyl diethylenetriamine 
(DETA), (United Chemical Technologies Inc. T2910) film was formed by the reaction of the 
cleaned and dried surfaces with a 0.1% (v/v) solution of the organosilane in freshly distilled 
toluene (VWR cat. nr. BDH1151).  The DETA-toluene solution was prepared in a glove box 
(MBraun, Stratham, NH) under nitrogen atmosphere, and the reaction was carried out in the lab 
atmosphere in a dish covered with an inverted beaker.  The dish containing the clean slides was 
heated to approximately 100°C for 30 minutes, and then allowed to cool to room temperature, 
when the slides were taken out of DETA solution, rinsed carefully three times with dry toluene 
and reheated in a fourth toluene rinse to approximately 100°C for 30 additional minutes. The 
DETA-coated slides were oven dried at 110°C for at least 2 hours prior to use or storage. 
Surfaces were characterized by static water contact angle measurements using a Rame-Hart 
Model 250 goniometer, and by X-ray Photoelectron Spectroscopy (XPS) using a VG ESCALAB 
220i-XL spectrometer equipped with an aluminum anode and a quartz monochromator. The 
spectrometer was calibrated against the reference binding energies of a clean Ag sample. XPS 
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survey scans were recorded in order to determine the relevant elements (pass energy of 50 eV, 
step size of 1 eV). Si 2p, C 1s, N 1s, and O 1s high resolution spectra were recorded in order to 
determine the quality of the surfaces (pass energy of 20 eV, step size of 0.1 eV). The fitting of 
the peaks was performed with Avantage version 3.25 software, provided by Thermo Electron 
Corporation.     
Skeletal Muscle Isolation and Serum-Free Medium 
 The left and right Tibialis Anterior (TA) were dissected from Adult Sprague-Dawley rats 
aged 6-12 months (Charles-River Laboratories). Briefly, rats were euthanized by inhalation of an 
excess of CO2. This procedure complies with IACUC standards laid out by the Animal Research 
Council of University of Central Florida. The muscle was collected in a 15 ml conical tube and 
washed briefly in PBS to remove debris. The tissue was then minced into fine pieces and 
enzymatically dissociated in a 25 mg collagenase II (Worthington Biochemicals, LS004176), 1 
mg dispase (Worthington Biochemicals, LS02104) solution in DMEM (Gibco, 11965) for 1 hour 
in a 37°C water bath at 100 rpm. Muscle was removed and triturated using fire polished glass 
pipettes. The suspension was plated on 100 mm uncoated dishes for 1 hour at 37°C, 100% 
relative humidity. The unattached cell suspension was collected and centrifuged at 300 g for 5 
min at 4°C. The supernatant was removed and the pellet was re-suspended in proliferation 
medium (Table 1) and plated on DETA coverslips. The suspension was allowed to incubate for 
45 minutes before additional medium was added. The cells were then serial plated twice on 
DETA coverslips to obtain a more pure population of myoblasts on the third coverslip. After 8 
days the proliferation medium was slowly removed and replaced with differentiation medium 
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(Table 2) to promote cell alignment and fusion. The cells were maintained in a 5% CO2 
incubator and one half the differentiation media was changed every 3-4 days. 
Table 1:  Composition of serum-free growth medium for a 500 ml sample 
Component Company Catalogue # Quantity
Neurobasal Invitrogen 21103049 250 ml
L15 Invitrogen 11415064 250 ml
aFGF Invitrogen 13241-013 10ug
Antibiotic-antimycotic Invitrogen 15240062 5 ml
Calcium chloride Fisher 10035-04-8 250ug
VEGF RND systems 293-ve-010 10ug
bFGF RND Systems 3339-FB-025 20ug
CNTF Cell Sciences CRC 401B 20ug
NT-3 Cell Sciences CRN 500B 10 ug
Nt-4 Cell Sciences CRN 501B 10ug
GDNF Cell Sciences CRG 400B 10ug
BDNF Cell Sciences CRB 600B 10ug
CT-1 Cell Sciences CRC 700B 10ug
LIF Sigma L5158 10ug
Vitronectin Sigma V0132 50ug  
 
Table 2: Composition of serum-free differentiation media for 500 ml 
Component Company Catalogue #Quantity
Neurobasal Invitrogen 21103049 250 ml
L15 Invitrogen 11415064 250 ml
EGF Invitrogen 53003018 50ug






 Coverslips were rinsed with PBS and fixed in 4% paraformaldehyde for 10 min. They 
were then washed in PBS, incubated in PBS supplemented with 1% bovine serum albumin and 
0.1% triton X-100 (permeabilization solution) for 20 min, before being blocked for 30 min in the 
permeabilization solution + 5% donkey serum (blocking solution). The fixed cells were 
incubated in blocking solution overnight at 4°C with either a primary antibody against MyHC all 
classes (A4.1025, IgG, Developmental Studies Hybridoma Bank), diluted 1:10, a MyHC slow 
antibody (Sigma M8421), diluted 1:500, or a MyHC fast antibody (abcam ab91506), diluted 
1:1000. Coverslips were washed with PBS and incubated with Alexafluor secondary antibodies 
(Invitrogen) diluted (1:400) in PBS for 2 hours at ambient temperature in the dark. After rinsing 
in PBS, the coverslips were mounted on glass slides using VectaShield + DAPI mounting media 
(Vector Laboratories H1200) and viewed on a confocal microscope (UltraVIEW™ LCI, 
PerkinElmer). For double staining with Pax-7 and Myo-D, cultures were processed for 
immunocytochemistry as just described. Next, cells were incubated overnight at 4°C with 
primary antibodies against Myo-D (abcam ab16148), diluted 1:1500, and Pax-7 (abcam 
ab34360), diluted 1:3000. 
Patch Clamp Electrophysiology 
Whole-cell patch clamp recordings of the mature myotubes were performed by Dr. Min 
Lin in a recording chamber located on the stage of a Zeiss Axioscope 2FS Plus upright 
microscope as described previously[36]. Patch pipettes were prepared from borosilicate glass 
(BF150-86-10; Sutter, Novato, CA) with a Sutter P97 pipette puller and filled with intracellular 
solution (in mM: K-gluconate 140, EGTA 1, MgCl2 2, Na2ATP 2, phosphocreatine 5, 
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phosphocreatine kinase 2.4 mg, Hepes 10; pH = 7.2). The resistance of the electrodes was 6–8 
MΩ. Voltage clamp and current clamp experiments were performed with a Multiclamp 700A 
amplifier (Axon Laboratories, Union City, CA). Signals were filtered at 2 kHz and digitized at 
20 kHz with an Axon Digidata 1322A interface. Data recording and analysis were done with 
pClamp 8 software (Axon Laboratories). Membrane potentials were corrected by subtraction of a 
15 mV tip potential, which was calculated using Axon's pClamp 8 program. Sodium and 
potassium currents were measured in voltage clamp mode using voltage steps from a −85 mV 
holding potential. Action potentials were evoked with 1 s depolarizing current injections from a 
−85 mV holding potential. 
Statistical Analysis 
 30 random fields of view were analyzed across 3 independent experiments. The number 
of fields of view analyzed was deemed sufficient to provide an accurate representation of the 








DETA surface Modification and Characterization 
 DETA is a spermidine analog that has been shown to promote the proliferation, 
maturation and, long term survival of an array of cell types [5, 31, 32, 35, 36].  Static contact 
angle and XPS analysis was used for validation of the surface modifications. Contact angles of 
46° +/- 2° were shown to be consistent and reproducible across this study. XPS measurements 
for the ratio of N (1s) to Si (2p) of 1500 +/- 200 indicated that a reaction site limited DETA 
monolayer was formed on the coverslips.  
Development of Serum-free Medium and Plating Technique 
 The starting medium formulation, surface modification and plating technique was 
developed previously by our lab to create a system for the development of myotubes derived 
from embryonic E18 rat hind-limbs[29].  However, this system was insufficient to enable the 
development of myotubes from satellite cells isolated from the TA of adult rats. The original 
medium formulation was altered by the addition of bFGF, which is well established as a 
promoter of muscle proliferation [5], L15 medium, which was previously shown to promote 
myoblast survival [29], and the addition of calcium, in the form of CaCl2 [37]. This reformulated 
medium was sufficient to promote the proliferation of myoblasts. The plating technique was 
modified by introducing a serial plating protocol whereby the cell suspension was removed after 
24 hours and re-plated on a new DETA coverslip [38]. After the second serial plating it was 
determined that the culture had a higher proportion of myoblasts and cell survival in the culture 
was increased.  
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After cell proliferation and culture purity were optimized, it was also necessary to alter the 
technique by which differentiation of myoblasts into myotubes was induced. The previously 
devised technique was to shock the cultures into differentiation by completely changing the 
growth medium to differentiation medium after 48 hours of proliferation [29]. It was observed 
that if this technique was employed, it resulted in complete cell death within 12 hours. Instead a 
gradual decline in growth factors was employed to enable, cell survival and maturation into 
multinucleated myotubes. 300 uL of growth medium was removed daily and replaced with an 
equivalent volume of a defined serum-free differentiation medium (Table 2) over the course of 5 
days.  This gradual reduction in growth factors resulted in robust cell survival and myotube 
formation. The combination of all these changes resulted in the establishment of a system by 
which mature myotubes could be routinely formed from adult satellite cells (Figure 3). 
Functional contractile in vitro myotubes tend to differ slightly from mature in vivo myofibers 
morphologically; they lack peripheral nuclei and, despite forming well-defined sarcomeric 
structures, they usually do not promote the formation of extensive and highly organized 
myofibrils. Therefore, for the purposes of this manuscript, these differentiated myogenic cells are 
referred to as functional myotubes, rather than myofibers. 
Characterization of the Satellite Cells and Resultant Myotubes 
 Satellite cells express the transcription factor Pax-7. Cells of a myogenic lineage will also 
express the muscle specific marker Myo-D. There is some contention as to whether Pax-7 is 
expressed in quiescent versus activated satellite cells, nevertheless it is ubiquitously expressed in 
satellite cells as a whole [39-41]. As such, these markers were used to quantify the number and 
purity of muscle satellite cells isolated from the TA. Figure 4 shows the co-localization of Pax-7 
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and Myo-D in myoblasts expanding in proliferation medium after 2 days in vitro (DIV). Multiple 
coverslips were imaged, using cumulative frequency analysis, and the cultures were determined 
to be 60.15% +/- 10.39% positive for both Pax-7 and MyoD in the first plating, 71.36% +/- 6.3% 
for the second plating, and 94.96% +/- 3.85% after the final serial plating (Figure 4). This 
establishes that serial plating was needed to provide a relatively pure culture of proliferating 
myoblasts that promotes myotube formation in the serum-free medium. Figure 4a, panels D-F, 
also shows phase images of the myotubes from 12 DIV, indicating the continued purity of the 
culture. 
Immunocytochemical Characterization of the Myotubes 
 After induction of myoblast fusion into myotubes the culture was characterized 
immunocytochemically. DIV 14 myotubes were stained with anti-MyHC antibody A4.1025 from 
the DSHB. MyHC is an essential element in the contractile apparatus of mature myotubes. 
Figure 6 shows highly striated muscle indicating mature myotubes with a highly developed 
contractile apparatus. 
Characterizing Mature MyHC Expression  
 One of the limiting factors in the use of embryonic derived cultures is the limitation for 
those cultures to express more advanced isoforms of MyHC such as neonatal and/or adult. [42, 
43] Figure 7 shows positive staining for both the mature MyHC slow isoform as well as the 
mature MyHC fast isoform. It was determined that approximately 73.89 ± 4.6% of myotubes at 
12 DIV expressed the MyHC fast twitch isoform and that 10.67 ± 1.1% of those myotubes also 
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expressed the mature slow twitch isoform. This is in contrast to previous results indicating 
approximately 25% neonatal/adult conversion after 45 DIV for embryonic derived tissue. [33] 
Electrophysiological Characterization 
 Muscle specific myoblasts were shown to fuse into MyHC positive myotubes. These 
myotubes were then tested to determine if the ion channels were functional utilizing whole cell 
patch clamp electrophysiology. DIV 14 myotubes were patched according to the described 
protocol and as can be seen in Figure 8 fired action potentials (APs) when stimulated. The 
myotubes expressed a mean inward current of -2998.7 +/- 307.9 pA with a mean outward current 
of 1816.3 +/- 202.2 pA indicating functional sodium and potassium channels and the APs had a 
mean amplitude of 46.7 +/- 5.8 mV (errors are expressed as +/- the SEM, with n = 9). The resting 
membrane potential of -59.9 +/- .8 mV measured in our system more closely mimics ideal in vivo 
potentials than previously reported membrane potentials of comparably aged in vitro rat 
myotubes in serum-containing medium. [44]  
Discussion 
 The results described above document the development of a new serum free adult skeletal 
muscle culture system. This system furthers the evolution of physiologically relevant in vitro 
myotube models. Specifically, this manuscript documents the development of a medium 
formulation, surface composition and culture technique that results in myotubes that better 
recapitulates in vivo functionality and maturation by more rapid expression of adult myosin 
isoforms compared to embryonic tissue-derived myotube cultures.  
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 Current in vitro muscle cultures derived from adult tissue primarily rely on animal sera 
for the division and growth of myoblasts. [45] The limitations of this approach are the variability 
of serum production and the lack of definition of the contents. A serum-free medium was 
developed, supplemented with a cocktail of defined growth factors supporting adult-derived 
myoblast proliferation and fusion as well as myotube maturation, both structurally and 
functionally. The completely defined nature of this medium formulation also makes it 
advantageous for high-content drug screening and in vitro/in vivo correlative studies. It could 
also be utilized in tissue engineering and regenerative medicine investigations by demonstrating 
new techniques for isolation and expansion of adult satellite cells that are capable of functional 
maturation. 
 Previously, studies conducted in our lab resulted in the development of a defined skeletal 
muscle myotube system derived from the hind-limbs of embryonic day 18 rat fetuses. [29] This 
culture system provided a starting point for studying myotube physiology in a serum-free 
environment, but was limited in its ability to reproduce in vivo mature muscle characteristics. 
This previous work has shown, and is supported by observations from our experiments, that 
MyHC class switching from an embryonic isoform to a more adult like phenotype occurs over a 
45-50 day culture period, after which the culture will express ~25% neonatal/adult MyHC 
isoforms. [29] While the use of DETA provides for long term muscle cultures, up to a maximum 
of 6 months in our hands (data not shown), it would be more time efficient and cost effective to 
have myotube cultures that express adult MyHC isoforms at earlier time points.   
We have shown here that skeletal muscle myofibers derived from the TA of adult rats 
undergo a more accelerated MyHC isoform switching than do their embryonic muscle 
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counterparts under these serum-free media conditions and using a defined organosilane surface. 
Figure 7 shows both mature MyHC fast-twitch fiber expression and MyHC slow-twitch fiber 
type expression by day 12 in culture. This equates to a 75% decrease in time to maturity over 
embryonic derived muscle in serum-free conditions. We have also shown that 73.89+/-4.6% of 
myotubes in culture at day 12 expressed the mature MyHC fast twitch isoform, and 10.67 +/-
1.1% of those also expressing the adult type slow twitch isoform; a 3-fold increase in mature 
MyHC expression over an embryonic-derived culture system. [29, 33, 46] The ratio of fast to 
slow twitch isoform expression in myotubes maintained for 12 DIV in serum-free conditions 
mirrors data attained using serum-containing media at equivalent time-points.  [43]  
  It was observed that 31.0% +/- 19.1% of the 12 DIV myotubes contracted spontaneously 
at any one time, as well as approximately 70% of myotubes contracted under broad field 
stimulation. [47] Further studies have shown that this new culture technique and medium 
formulation allows for the interrogation of myotube contractile force and fatigue. [47]  This 
system will allow for ease of isolation of tissue, reduction in culture cost for media, reduction in 
time to analysis, and increased relevance to mature muscle, making it a more representative 
culture system to study adult myopathies. This formulation is also compatible with neuronal 
culture, so it should facilitate multi cellular construct formation in vivo. Furthermore, the adult 
nature of the myoblasts used in this system facilitates the accurate investigation of adult 
myopathies, muscle regeneration and neuromuscular junction physiology. This opens new 
possibilities of directly culturing cells from transgenic animals after they began exhibiting their 




 In conclusion, this serum-free skeletal myotube culture system  provides a model by 
which to investigate the role specific growth factors and drugs might play on adult physiological 
processes such as myotube maturation as well as disease processes associated with muscle 

















Figure 3: Phase images of myoblasts and myotubes derived from the Tibalias anterior of adult Sprague Dawley rats. 
Phase images of proliferating myoblasts at (A) 2 DIV, (B) 4 DIV, (C) 8 DIV. Phase images of fused myoblasts at 12 













Figure 4: Pax-7 and Myo-D immunostaing of 2 DIV myoblasts derived from plate three of serial plating. (A) Phase 
image of myoblasts, (B) Pax-7 transcription factor staining, (C) Myo-D muscle marker staining. Phase images 
indicating the relative purity of myotube cultures from serial plating at 12 DIV. (E) Plate 1, (D) Plate 2, (F) Plate 3. 

































Figure 6: (A) Phase image (B) MYHC immunostaining and (C) overlay of 14 DIV myotubes. A4.1025 MyHC 
antibody staining showing highly striated myotubes. Striations are an indication of a highly organized contractile 
















Figure 7: Immunostaining of 12 DIV myotubes for adult MyHC isoforms. Panels (A and D) show staining for adult 
MyHC type I isoform for two separate coverslips. Panels (B and E) show staining for adult MyHC type IIb isoforms 
for those same myotubes. Panels (C and F) are the composite images of those cultures. Cultures indicate at 12 DIV 
73.89 ± 4.6% of myotubes stain for type IIb and approximately 10.67 ± 1.1% of those also stain for type I isoform. 












Figure 8: Patch clamp electrophysiology of adult tissue derived myotubes. (A) Representative voltage clamp trace 
obtained from a 14 DIV myotube. (B) Representative current clamp trace of same myotube. Inset is a phase image 














CHAPTER THREE: MECHANISTIC INVESTIGATION OF ADULT 
MYOTUBE RESPONSE TO EXERCISE AND DRUG TREATMENT IN 
VITRO USING A MULTIPLEXED FUNCTIONAL ASSAY SYSTEM 
Introduction 
 The development of advanced cell culture systems, capable of accurately measuring the 
functional output of a variety of cell and tissue types, is one of the targets of recent efforts to 
engineer complex, physiologically relevant in vitro assay systems for drug-development and 
disease modeling applications. [48] Skeletal muscle is one tissue for which in vitro analogues 
have been developed which are capable of effectively recapitulating the functional maturation 
and performance of the native tissue, through controlled stimulation and measurement of the 
contractile output of embryonic [49, 50]  neonatal/adult [51-53] and human  cultured cells. [54] 
Such systems represent exciting possibilities for drug toxicity/efficacy studies, as well as for the 
modeling of human disease states in vitro. New in vitro systems that extend these studies to 
allow functional assessment of muscle maturation and recovery from injury would also be 
beneficial for advanced exercise physiology applications.   
Importantly, the integration of these functional skeletal muscle models with established 
long-term stimulation parameters and/ or hypertrophic drug treatments such as creatine will 
allow investigators to effectively simulate and assess muscle building and exercise in vitro [10, 
11, 53] Application of such technology could have important implications for the study of the 
training regimes used by elite athletes, as well as for developing appropriate therapies for 
patients with muscle wasting conditions such as muscular dystrophy and sarcopenia. Previous 
work in this field has focused on assessment of the molecular responses and metabolic output of 
skeletal muscle cells subjected to bouts of in vitro exercise and/or drug treatment. [20, 55-57] In 
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creatine studies, increased transcript expression for contractile machinery proteins, such as 
Myosin Heavy Chain (MyHC), have been observed in treated cultures. [56, 58]  Similarly, an 
increase in gene expression for markers of mitochondrial biogenesis and measurements 
suggesting increased glucose metabolism in cells subjected to in vitro exercise protocols has 
been reported. [10, 11, 59] However, to date very little work has been done on directly 
measuring the cell’s functional response to such in vitro stimulation regimes. Hence, there 
remains some ambiguity as to whether the molecular and metabolic changes observed in 
response to in vitro exercise correspond to a measureable change in the contractile behavior of 
cultured cells. Moreover, no published work has yet studied the effect of in vitro exercise on 
muscle fiber (myotube) fatigue, meaning little is known about the fatigability of cultured muscle, 
or how it compares to the in vivo tissue. Verifying an improvement in cultured skeletal muscle 
myotube contractility in response to exercise, as well as establishing a physiologically accurate 
model of fatigue, would be an important step in the development of a functional systems to 
model exercise physiology in vitro.  
In this study, a previously reported [60, 61] serum-free, multiplexed assay system 
utilizing silicon cantilevers was used to record the contractile output of adult rat skeletal muscle 
cells subjected to long-term stimulation protocols and creatine treatment. Both long-term 
stimulation and creatine treatment produced improved peak force (PF) and time to fatigue (TTF) 
data, as well as increased transcript expression for MyHC and mitochondrial biogenesis markers 
in line with previously published reports. These data highlight not only the functional 
improvement of muscle cells subjected to bouts of in vitro exercise, but also their biologically 
correct hypertrophic response to treatment with a known muscle building compound. The use of 
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multiplexed micro-scale cantilevers facilitates the interrogation of individual myotubes [21, 56, 
58, 62], allowing analysis of the effects of exercise and/ or drug treatment at the single cell level 
but since each cantilever is a separate experiment, with a high statistical power. Mathematical 
scaling of measured outputs is possible using this model, enabling data obtained at the single cell 
level to be used in predictions of whole tissue responses to physical and chemical challenges. 
Materials and Methods 
Cantilever Fabrication and Surface Preparation 
Cantilever chips were fabricated from silicon wafers, using previously published 
methods. [33, 50] Briefly, 100 mm Silicon-On-Insulator (SOI) wafers had a 4 µm thick device 
layer and buried oxide layer of 1 µm. In the device layer, the cantilevers were patterned using 
S1818 photoresist and etched using deep reactive ion etching (DRIE). To protect the cantilevers 
during processing, a 1 µm layer of silicon dioxide was deposited on the top surface. The bottom 
of the wafer was similarly patterned and etched so that the silicon beneath the cantilevers was 
removed, producing a large window underneath. The oxide layers were removed using a 
buffered oxide etch solution. The resulting structures were silicon cantilevers that could be 
imaged from above and interrogated with a laser from below.  
These cantilevers, as well as the coverslip controls used in this study, were coated with an 
amine-terminated alkylsilane, (3-Trimethoxysilyl propyl) diethylenetriamine (DETA) (United 
Chemical Technologies, Bristol, PA) using methods previously described. [5, 35, 36, 50] DETA 
is an analog of spermidine, which is known to promote long-term survival of cells in vitro, and 
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has been previously validated in the culture of various cell types. [31, 32] Thus it was used in 
this study as a surface coating, to promote cell adhesion and survival.  
The silanization of the cantilever surfaces with DETA was performed using a solution of 
0.1% (v/v) DETA-silane in toluene, heated to 70°C for 30 minutes, followed by a series of 
toluene rinses and reheating to 70°C for 30 minutes in fresh toluene to remove any unreacted 
silane. The surfaces were oven cured at 110°C for 2 hours and stored in a desiccator until use. 
The surface coating composition was verified using X-ray photoelectron spectroscopy and 
contact angle goniometry. 
Dissection and Cell Culture 
Adult rats were euthanized using excess CO2 in accordance with IACUC standards. The 
Tibialis Anterior muscles were isolated from the left and right hind limbs. The muscles were 
placed in a dish containing phosphate buffered saline (PBS), and scalpels were used to remove 
excess skin and hair. The muscles were then transferred to a Petri dish containing an enzyme 
solution consisting of 20 mL Dulbecco’s Modified Eagle’s Medium (DMEM), 25 mg 
collagenase type I (Worthington, Lakewood, NJ) and 1 mg neutral protease (Worthington, 
Lakewood, NJ). The tissue was minced in this dish, and the resulting fragments were transferred 
to a 50 mL conical tube. This tube was placed horizontally in a 37°C water bath and left for 1 
hour at 100 rpm. Following this enzymatic digestion, the tube was removed from the water bath 
and its contents were mechanically triturated and filtered through a 100 µm mesh to remove 
undigested tissue fragments. The tube was then centrifuged at 400 G for 4 minutes. The cell 
pellet was re-suspended in 20 mL of DMEM, and then separated into 2 100 mm Petri dishes. 
These dishes were placed in an incubator for 45 minutes to allow adhesion of fibroblasts to the 
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surfaces, and so enrich the non-adherent population for myogenic cells. The dishes’ contents 
were then collected in a 50 mL tube and centrifuged again at 400 G for 4 minutes. The cell pellet 
was re-suspended in 4 mL of proliferation medium (Table 3) and plated onto 4 DETA coverslips 
in a 12 well plate and was left to incubate overnight. The following day, the medium was 
collected into a 50 mL tube and centrifuged at 400 G for 4 minutes. The supernatant was 
removed and the cell pellet was again re-suspended in proliferation medium. The cells were 
plated onto 7 coverslips and 6 cantilever chips and left overnight. The following day, the 
medium on these plates was aspirated and 1 mL fresh proliferation medium was added to each 
well. Once the plated cells achieved confluency and myotubes began to form (at about 6 days 
after the first plating), 500 µL of differentiation medium (50:50 Neurobasal:L15 medium plus 10 
ng/ml insulin-like growth factor) was added to each well. Every 4 days subsequently, half the 
culture medium on each well was replaced with fresh differentiation medium. Cultures were 
maintained for 7-9 days after addition of differentiation medium prior to analysis. 
Table 3: Composition of serum-free growth medium components in 50:50 neurobasal:L15 medium 
Component Company Catalogue # Quantity
Antibiotic-antimycotic Invitrogen 15240062 5 ml
aFGF Invitrogen 13241-013 20ng/mL
Calcium chloride Fisher 10035-04-8 500ng/mL
VEGF RND systems 293-ve-010 20ng/mL
bFGF RND Systems 3339-FB-025 40ng/mL
CNTF Cell Sciences CRC 401B 40ng/mL
NT-3 Cell Sciences CRN 500B 20ng/mL
NT-4 Cell Sciences CRN 501B 20ng/mL
GDNF Cell Sciences CRG 400B 20ng/mL
BDNF Cell Sciences CRB 600B 20ng/mL
CT-1 Cell Sciences CRC 700B 20ng/mL
LIF Sigma L5158 20ng/mL
Vitronectin Sigma V0132 100ng/mL  
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Chronic Low-Frequency Stimulation (CLFS) Protocol and Creatine Treatment 
 After 7-9 days in differentiation medium, 2 cantilevers and 1 coverslip were placed into a 
chronic low-frequency stimulation apparatus. The remaining cantilevers and coverslips were 
used as unstimulated controls. The apparatus consisted of carbon electrodes housed in a 6 well 
plate and connected to a pulse stimulator. Electrical pulses had a magnitude of 3 V, with a pulse 
width of 1.5 ms; 5 pulses were delivered to the cultures at 20 Hz every 4 seconds. This 
stimulation protocol was devised based on previously published work [63, 64]. The cultures were 
incubated at 37°C within this apparatus for 4-7 days, and the medium was replaced every other 
day. Similarly, cultures were fed with medium supplemented with 40 mM creatine (Sigma) 
following 7-9 days in differentiation medium. Cultures were maintained in creatine containing 
medium for a further 4-7 days before analysis and the medium was replaced every other day. 
Peak Force and Time-to-Fatigue Calculation 
 A laser and photo-detector system, adapted from Atomic Force Microscopy technology, 
was utilized to calculate peak force (PF) of individual myotube contractions, as well as the 
myotubes’ time-to-fatigue (TTF) (Figure 10). Application of this system for similar studies has 
been described in detail elsewhere[60, 61]. Each cantilever chip was transferred to a heated stage 
housed within a modified electrophysiology rig. The culture dish on this heated stage was filled 
with Differentiation Medium (+10 mM HEPES) to maintain the cells during analysis.  
 Briefly, the automated system consisted of a class 2 photodiode laser positioned below 
the stage so that the beam was focused on the cantilever tip and reflected into the center of a 4-
quadrant photo-detector. [49, 65]. A pulse stimulator was used to generate pulses capable of 
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eliciting contraction in the cultured myotubes. The biphasic pulses were 3V in magnitude and 
had a pulse width of 40 msecs with a frequency of 1 Hz. The resulting cantilever deflection was 
measured in terms of laser displacement (in V). Software was written in labVIEW (National 
Instruments) to control laser and photo-detector positioning to allow scanning across all 
cantilevers on each chip for contractile activity. The acquired raw data was converted into a 
direct measurement of force using a modified Stoney’s equation. Previous work[60] had 
demonstrated that measurements analyzed using the Stoney equation with a similar cantilever 
system exhibited strong correlation with data generated using finite element analysis, which 
takes into account a more detailed set of cell dimensions when calculating force production. The 
assumptions made for analysis using Stoney equation were therefore deemed acceptable for 
determining changes in force production per cell in response to creatine treatment and long-term 
stimulation.  
To determine which cantilevers had contracting myotubes, the chip in the culture dish 
was first subjected to broad field electrical stimulation using the stimulation parameters listed 
above. The cantilevers were scanned for 5 seconds each to elicit and record contractile responses. 
The active cantilevers were then scanned, with continuous electrical stimulation, until their peak 
force was reduced by half. Thus, the time-to-fatigue was calculated by measuring the time 
elapsed in which a 50% reduction in peak force was observed. Subsequent bright-field images 
were collected of each contracting cantilever and those supporting multiple myotubes were 
discounted from further analysis to ensure the calculation of force generated per myotube was 
accurate. Preliminary studies were performed to ensure that this 50% reduction in PF was 
indicative of myotube fatigue and not physical damage to the myotubes such as tearing of the 
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sarcolemma induced by stimulation. After a 7 minute rest and recovery period approximately 
88% of original PF was observed, suggesting force reduction was indeed due to cellular 
exhaustion (Data not shown). 
Immunocytochemistry 
Cells were fixed for 10 minutes in 4% paraformaldehyde in PBS. These cultures were 
then permeabilized with 0.1% Triton-100 in PBS for 20 minutes followed by a 20 minute 
incubation in 5% donkey serum with 0.1% Bovine Serum Albumin (BSA) in PBS (Blocking 
solution). The blocking solution was then removed and the cells were further incubated overnight 
at 4°C in a primary antibody solution consisting of a mouse monoclonal antibody against MyHC 
(DSHB A4.1025) at a 1:10 dilution in blocking solution. The cells were washed 3 times with 
PBS and then incubated in the dark for 2 hours at room temperature with a secondary antibody 
solution consisting of a donkey anti-mouse Alexafluor-594 conjugate diluted 1 in 200 in 
blocking solution. The cells were washed 3 times in PBS before being mounted on microscope 
slides using a hard-set DAPI containing mounting medium (Vectashield) for visualization. 
Quantitative Polymerase Chain Reaction (qPCR)  
Samples designated for PCR analysis were homogenized in TRIzol reagent and the RNA 
isolated according to the manufacturer’s protocol. Purified RNA was converted to cDNA and the 
qPCR reactions run using the BIO-RAD iScript™ One-Step RT-PCR kit with SYBR
®
 Green 
(BIO-RAD Laboratories, Hercules, CA - catalog #170-8892) according to the manufacturer’s 
protocol. Briefly, the PCR reaction mixture (12.5 µL 2x SYBR
® 
Green RT-PCR reaction mix, 
0.5 µL iScript reverse transcriptase, 0.75 µL forward primer, 0.75 µL reverse primer, 10 ng RNA 
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template and nuclease-free water to a total reaction volume of 25 µL) was prepared for each gene 
to be analyzed from each sample in triplicate wells of a 48 well plate. PCR primers used in this 
study were taken from those previously tested and verified (Table 4). [66] The reaction plate was 
then transferred to an MJ Mini thermal cycler (BIO-RAD) and incubated at 50°C for 10 minutes 
and 95°C for 5 minutes before being cycled 40 times at 95°C for 10 seconds, followed by 60°C 
for 30 seconds. The qPCR protocol and fluorescent output from the reactions were implemented 
and recorded using Opticon Monitor software (BIO-RAD). 
 
Table 4: PCR primer sequences 
 
Gene Sequence (5' to 3')
MyHC 1 FWD GCCAACTATGCTGGAGCTGATGCCC
MyHC 1 REV GGTGCGTGGAGCGCAAGTTTGTCATAAG
MyHC 2A FWD GGCACAAAACTGCTGAAGCAGAGGC
MyHC 2A REV GGTGCTCCTGAGGTTGGTCATCAGC
MyHC 2B FWD GCAGCTACTGGATGCCAGTGAGCGC
MyHC 2B REV CTGGACGATGTCTTCCATCTCTCC
MyHC 2X FWD GGCAGCAGCAGCTGCGGAAGCAGAGTCTGG
MyHC 2X REV GAGTGCTCCTCAGATTGGTCATTAGC
PGC-1 α FWD GTGCAGCCAAGACTCTGTATGG
PGC-1 α REV GTCCAGGTCATTCACATCAAGTTC
ERR-γ FWD TGACTTGGCTGATCGAG
ERR-γ REV CCCAGGATCAAGATTTCC  
 
The threshold cycle (CT) was defined as the fractional cycle at which the fluorescence 
generated by the binding of SYBR
®
 Green molecules to double-stranded DNA exceeded a fixed 
threshold above the baseline. The amount of each target gene present in the sample was 
quantitated using the comparative CT method.[67].  Mean CT values from triplicate reactions for 
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each sample were determined and normalized to that of an endogenous housekeeping gene (β-
actin) run in parallel. The amount of target amplification relative to the endogenous control was 




The width of myotubes cultured on cantilevers was measured as a means to estimate 
cross-sectional area (CSA). Phase-contrast images were collected using a Zeiss Axiovert 200 
inverted microscope and analyzed using ImageJ software. Lines were drawn vertically across 
each image at points 1/3 from each edge of the field of view. The width of each myotube that 
crossed either of these lines was measured at that point to eliminate selection bias. 
Statistical Analysis 
 All experiments were repeated at least 3 times using cultures prepared on different days, 
with tissue from different animals. Differences in force and time-to-fatigue measurements among 
the three conditions (“Untreated”, “CLFS”, “Creatine-Treated”) were each evaluated statistically 
using one-way repeated measures ANOVA (α = 0.05). Following the repeated measures 
ANOVA with a statistically significant F-statistic, means were compared using Tukey’s HSD 
test for multiple comparisons (α = 0.05). QPCR expression data for CLFS and creatine-treated 
samples were expressed relative to untreated controls; as such, control values were always 1. For 
these experiments, a one-sample T-Test was used to calculate whether or not mean expression 






 Primary adult rat skeletal muscle myotubes were maintained on silicon cantilevers for 14 
days in differentiation medium before being analyzed for contractile function. 
Immunocytochemical analysis at this time-point demonstrated the development of a distinct 
striated morphology, indicating the formation of mature and functionally capable sarcomeres 
within these cells (Figure 9). This end-point enabled maximal levels of myotube differentiation 
and maturation (approximately 70% of cultured myotubes responded to broadfield stimulation), 
while minimizing myotube loss due to detachment and thereby maximizing data collection. 
Functional Assessment of Cultured Myotubes 
 Using the described protocol, contractile activity was recorded from the cultured 
myotubes, verifying the ability for this system to measure the functional contraction (Figure 
10A). Continuous recording of stimulated cantilever cultures indicated substantial reductions in 
PF measurements over extended periods that enabled the assessment of skeletal muscle fatigue in 
real-time (Figure 10B). Analysis of functional data from the experimental conditions 
demonstrated that both creatine treatment and long-term stimulation produced significant 
increases in PF compared with untreated controls (Figure 11A, p<0.02). No significant 
differences were observed between creatine treated and CLFS cultures over 4 or 7 day 
applications (p>0.5). Similarly, creatine and CLFS regimens were found to statistically increase 
the TTF capacities of cultured myotubes roughly 5 fold, when compared with untreated controls 
(Figure 11B, p<0.001). No significant differences in TTF were observed between any of the 
treatment regimens examined (p>0.6). These combined data suggest that each treatment regime 
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examined was capable of promoting the same magnitude of functional improvement in myotube 
performance over the time-course investigated in this study. 
Assessment of Hypertrophy in Cultured Myotubes 
 During the culture of the primary adult skeletal muscle cells, it was observed that creatine 
treated cultures developed substantially thicker myotubes than all other conditions examined 
(Figure 10). Image analysis confirmed that 4 and 7 day creatine treated cultures promoted a 
significant increase in myotube CSA compared with both CLFS and untreated controls (n =3, 
p<0.0001). Both creatine treatment and CLFS were found to improve functional performance but 
only creatine treatment produced a significant hypertrophic response in the cultured myotubes. 
The collected data therefore implied that the observed differences in functional performance 
between treated and untreated cultures were due to the adaptation of different molecular 
mechanisms activated through the two methods of myotube stimulation employed. 
Gene Expression Analysis of Cultured Myotubes 
 Data collected from qPCR experiments highlight that both creatine treatment and CLFS 
have a significant effect on transcription profiles within primary adult myotubes in vitro. 
Application of creatine to cultured cells for 4 days produced a 2 to 4 fold increase in all MyHC 
transcripts examined (n = 4, p<0.002, Figure 13), whereas four day CLFS protocols were found 
to promote an upregulation in estrogen related receptor (ERR) γ transcripts (n = 3, p<0.03). The 
differences observed in upregulated genes within these cultures highlight the alternative 
pathways activated by the treatment regimens examined. The collected data confirmed the 
physiological differences in myotube CSA discussed earlier, and is in line with previously 
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published work assessing the hypertrophic effect of creatine on skeletal muscle and the cellular 
response to chronic exercise regimes in vivo and in vitro. [21, 62, 68]  
Discussion 
 The development and widespread application of an in vitro model of exercise and fatigue 
capable of modelling skeletal muscle functional response would be of substantial benefit to 
exercise physiology studies and investigations of muscle building and wasting. While three-
dimensional cultures have obvious advantages for modeling whole tissue behavior, multiplexed, 
two-dimensional systems are more easily adapted for application in high-throughput drug 
efficacy/toxicity studies. Furthermore, the ability to record contractile data from individual 
myotubes is useful for examining alterations in individual muscle fiber phenotype in healthy and 
diseased states. Multiplexed cantilever assays provide information on maturation and 
performance variability between myotubes, and provide multiple data points for the generation 
of more statistically relevant observations. Analysis of 3D myotube bundles either relies on 
integration of invasive force transducers or lower resolution optical mapping. The non-invasive 
nature of the cantilever analysis system means cultures can be reanalyzed at multiple time-points 
for continued assessment of individual cells. The high resolution data acquisition system, 
utilizing laser and photo-detector hardware, enables higher sampling rates (1000 Hz) than optical 
techniques (5 – 500 Hz), facilitating more in depth analysis of changes in functional contractile 
waveforms. Finally, 2D systems such as the one described here are likely to be more readily 
integrated with complex, multi-cell-type platforms for body-on-a-chip applications [48, 69, 70] 
and for developing phenotypic assays for drug evaluation. 
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Previous work in this lab has developed and optimized this cantilever system for 
assessing embryonic myotube development. [61, 65]  While such a culture model is beneficial as 
a proof of principle, application of this technology to investigate age-related myopathies and 
exercise regimens in aged tissue would benefit from integration of the cantilever platform with 
cells derived from adult tissue. This study builds on the published data to utilize a cell population 
derived from adult tissue within a functional in vitro assay system designed to quantify 
contractile responses in real-time and over extended periods in response to both drug and 
exercise treatments. 
The collected data demonstrate that this multiplexed cantilever array can be used to 
effectively monitor rates of muscle fatigue in vitro. While previous work from a number of 
groups [59, 63, 64, 71] has used long-term stimulation and creatine treatment to evaluate 
molecular changes during cellular development in vitro, this study is the first to assess the effect 
of such treatment applications on long-term functional performance. Such data is important for 
confirming that the molecular changes observed in vitro correlate to alterations in functional 
output, thereby validating such studies for producing predictions of whole tissue responses in 
vivo.  
Analysis of the cultured cells highlights that both peak force generation and rates of 
fatigue improve significantly in response to either creatine or long-term stimulation protocols. 
The observed improvements to myotube output and endurance correlate to established data 
evaluating the effects of similar treatments in vivo. [22, 72-75] Assessment of gene transcription 
profiles in treated cells suggests that the improvements to functional output induced by these 
treatments are facilitated by activation of different molecular mechanisms. Creatine application 
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promoted a hypertrophic response in the cultured cells, leading to the upregulation of contractile 
protein apparatus and the maturation of sarcomeric structures, resulting in myotubes with 
significantly larger cross-sectional areas compared with untreated controls (Figures 12, p 
<.0001). Long-term stimulation is known to initiate alterations in transcription of genes relating 
to mitochondrial biogenesis, such as ERRγ. [55, 68, 76]  Upregulation of these genes likely 
induces increased mitochondrial presence within these cells, facilitating a greater endurance 
capacity. [55, 57]  This understanding of the effects of long-term stimulation on skeletal muscle 
is supported by the data presented in this study (Figure 13).  
Improvements to peak force observed in CLFS cultures suggest the repeated stimulation 
likely also had an effect on sarcomeric development in these cultures. No significant difference 
was observed in PF production between creatine treated cultures and those subjected to CLFS. 
However, significant differences in myotube CSA were observed between these culture 
conditions. Together, this data implies that creatine treatment promoted a hypertrophic response, 
leading to greater myotube volumes and therefore more cytoplasmic space for sarcomere 
formation resulting in greater PF production. Since no hypertrophic response or upregulation of 
MyHC transcripts was observed in CLFS cultures, the observed improvements in force likely 
result from improved development of the sarcomeres already present within these cells. 
Previously reported results indicate evidence for the upregulation of myosin synthesis in 
electrically stimulated in vitro cultures utilizing chick [19] and C2C12 cell lines. [67]  On the 
surface, these data seem contradictory to those presented in this manuscript.  However, there are 
significant differences between this work and those published previously that inhibit direct 
comparison.  Our protocol provides a defined, serum-free medium formulation which eliminates 
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many unknown factors contributed to the culture system by fetal bovine serum addition. The use 
of serum in the cited work may have led to the generation of significantly altered responses to 
electrical stimulation, due to the activation of different pathways by unknown factors in the 
medium. The use of our defined culture system obviates this issue, thereby providing a more 
controlled environment for investigating the direct effects of electrical stimulation on culture 
maturation and development. Furthermore, our functional assay system utilizes cells derived 
from adult rat tissue, which may demonstrate significantly different physiological responses to 
long term electrical stimulation than alternate cell sources.   
This study provides baseline parameters for measuring endurance of single fibers in vitro. 
While previous studies have characterized fatigue parameters in vivo, this study is the first to do 
so for in vitro muscle fibers. As such, it was necessary to determine an appropriate level of peak 
force decline which could be taken as evidence of muscle fatigue. Using the described functional 
assay, it is not possible to characterize a 100% force reduction since the baseline fluctuations 
make such small recordings unreliable. Muscle failure, as is measured in vivo, is not possible to 
investigate in this system since failure does not necessarily confirm that the muscle fibers are no 
longer contracting, but rather that they are no longer able to generate sufficient force to 
overcome the mass of the animal. It is not clear at what point this occurs and how much 
variability exists between different muscle types and between individuals. The parameters 
assessed in this study provide the means to compare between experimental repeats and facilitate 
normalization of measurements to a consistent evaluation of cellular exhaustion to potentially 
produce a more reliable assay of muscle function than some in vivo models. Measurement of a 
50% reduction in peak force is sufficient to reliably compare fatiguability between experimental 
42 
 
samples while restraining experimental lengths to a time-frame which would facilitate 
investigation of multiple cellular phenotypes and/or treatments on a given day.    
 
This system demonstrates, for the first time, the capacity to directly measure both 
absolute peak force and rates of fatigue in individual cultured myotubes. The developed system 
thereby allows full functional assessment of skeletal muscle responses to both small molecule 
treatment and exercise regimes controlled via broad field electrical stimulation. The successful 
application of cells derived from adult tissue and maintained in serum-free defined culture 
conditions makes this model appropriate for investigations of adult myopathies and/or drug 
efficacy and toxicity studies by utilizing a phenotypic assay system. The model is also 
appropriate to combine with molecular biological techniques for advanced mechanistic studies, 
as well as target identification in drug evaluations. Further development of this model to improve 
its high-throughput nature will likely be beneficial to future pre-clinical screening technologies 













Figure 9: Images of adult derived skeletal muscle myotubes. Phase contrast images of myotubes on silicon 
cantilevers at A) 10x and B) 20x. C)  Immunostaining of cultures using an antibody against MyHC all classes 















Figure 10: Measurement of force generation and fatigue. A) A representative peak force trace indicating how peak 
force is measured as a change in voltage by the photo-detector. This change in voltage can be converted using a 
modified version of Stoney’s equation to force in nN. B) Representative traces of peak force at initial time (15s) and 
when peak force has reached a 50% reduction in force (4800s). Recordings were measured in Volts then converted 













Figure 11: Comparison of peak force and fatigue. A) Graphical representation of peak force changes of four and 
seven day creatine and CLFS treatment regimens p<0.02. B) Graphical representation of time to fatigue changes of 














Figure 12: Assessment of hypertrophy in cultured myotubes. Phase images of multinucleated myotubes in A) 
control, B) CLFS, and C) creatine treated cultures. Scale bar = 50 µm. D) Graphical comparison of myotube 







Figure 13: Gene expression analysis of cultured myotubes. The gene expression profiles for myotubes undergoing a 
four day treatment of either CLFS or creatine were assessed using real-time quantitative PCR analysis. All MyHC 
genes were significantly upregulated under creatine treatment ** p<0.002, *** p<0.0001. CLFS treatment resulted 
in a greater than fourfold upregulation in ERR-γ transcripts, * p<0.03. This PCR analysis suggests different 





CHAPTER FOUR: A MULTIPLEXED HIGH-CONTENT FUNCTIONAL 
IN VITRO ASSAY TO ASSESS THE EFFECTS OF PGC-1α 
MISREGULATION ON MOUSE MYOTUBE ENDURANCE 
Introduction 
 The development of in vitro assay systems capable of accurately and reliably measuring 
the functional output of a multitude of cell types is important in the advancement of drug 
discovery and toxicity studies.  Skeletal muscle is one cell type in which in vitro systems adept at 
recapitulating in vivo functional output has been well characterized.  Tissue engineering of 
skeletal muscle has made considerable progress over recent years in the ability to integrate these 
cells into functional devices which are capable of measuring force output of single myotubes as 
well as myofibers in 2D and 3D in vitro environments[50, 54, 61, 65].  Current advances in these 
in vitro systems have made great strides in scaling up content recovery while scaling down the 
amount of tissue needed for functionality. These systems represent exciting avenues for the 
modeling of human disease and drug efficacy studies.    
In vitro muscle culture systems have been successful in recapitulating the in vivo 
transcriptional and translational effects that occur as a result of peroxisome proliferator-activated 
receptor gamma coactivator 1-alpha (PGC-1α) mis-regulation.  Specifically, the alterations in 
downstream proteins responsible for muscle and fat development as well as mitochondrial 
biogenesis have been interrogated[77, 78].   Simultaneously, in vivo/in situ studies have also 
shown that deviations in PGC-1α expression effect mitochondrial biogenesis and subsequently 
the endurance of skeletal muscle.  The modeling of disease states has benefitted greatly from the 
ability to culture cells derived from protein deficient, “knockout”, tissue.  In vitro systems have 
also shown the ability to measure functional force output of disease state and healthy skeletal 
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muscle tissue[79]. However, these systems are limited in their ability to accurately measure the 
endurance profile of the muscle utilized. An in vitro system capable of measuring muscle 
functional parameters such as force output and fatigue of healthy, disease state, and drug treated 
tissue, especially in a high-content manner, could have important implications for the study of 
the exercise regimes used by highly trained athletes and soldiers, drug efficacy studies, as well as 
give overall insight into the exercise physiology of muscle. 
In this study, a serum-free, high-content assay system utilizing silicon cantilevers was 
used to investigate the functional force output and endurance of mouse skeletal muscle whereby 
PGC-1α has been mis-regulated.  The down-regulation of PGC-1α caused a significant decrease 
in endurance while in contrast an up-regulation of PGC-1α exhibited a significant increase in 
myotube endurance profiles.  Neither up-regulation nor down-regulation of PGC-1α caused 
changes in the initial peak force (PF) output of the skeletal muscle myotubes.  These data are in 
line with previously published in vivo phenomenon related to alterations in PGC-1α 
expression[80, 81].  We have established a high-content monitoring system for the recapitulation 
of in vivo phenomenon on an individual cell scale 
Material and Methods 
Dissection, Cell Culture, and Drug Incubation 
 PGC-1α deficient mice were derived from a previously established protocol[82].  Adult 
mice, both WT and KO, were euthanized using excess CO2, in accordance with IACUC 
standards.  The Gastrocnemius was removed from both the left and right hind limbs.  The muscle 
was then processed according to previously established protocols[83, 84].  Briefly, muscle was 
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minced and incubated in a digestion solution consisting of 20 mL Dulbecco’s Modified Eagle’s 
Medium (DMEM), 25 mg collagenase type I (Worthington, Lakewood, NJ), and 1 mg neutral 
protease (Worthington, Lakewood, NJ).  The cells were then triturated, spun down, and 
resuspended in DMEM in a 90mm dish for 45 minutes to remove fibroblasts.  This solution was 
transferred to a 50 mL conical tube and spun down to pellet.  The resulting pellet was then 
resuspended in a previously defined growth medium and serially plated every 24 hours to 
enhance the percentage of myogenic cells.  Once the cells had reached confluency, 500 µL of 
differentiation medium was added to each well. Every 4 days subsequently, half the culture 
medium on each well was replaced with fresh differentiation medium. Cultures were maintained 
for 13-14 days after addition of differentiation medium prior to analysis. For the drug treated 
muscle, WT myotubes were incubated for 24 hours in 10 ng/ml of SBI-477 drug solution 
(courtesy of the Sanford-Burnham medical research institute) prior to testing. 
Cantilever fabrication and surface preparation 
Cantilever chips were fabricated from silicon wafers, using previously published 
methods[29, 65, 85]. Briefly, 100 mm Silicon-On-Insulator (SOI) wafers had a 4 µm thick 
device layer and buried oxide layer of 1 µm. In the device layer, the cantilevers were patterned 
using S1818 photoresist and etched using deep reactive ion etching (DRIE). To protect the 
cantilevers during processing, a 1 µm layer of silicon dioxide was deposited on the top surface. 
The bottom of the wafer was similarly patterned and etched so that the silicon beneath the 
cantilevers was removed, producing a large window underneath. The oxide layers were removed 
using a buffered oxide etching solution. The resulting structures were silicon cantilevers that 
could be imaged from above and interrogated with a laser from below.  
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These cantilevers, as well as the coverslip controls used in this study, were coated with an 
amine-terminated alkylsilane, (3-Trimethoxysilyl propyl) diethylenetriamine (DETA) (United 
Chemical Technologies, Bristol, PA) using methods previously described[29, 65, 85].  DETA is 
an analog of spermidine, which is known to promote long-term survival of cells in vitro, and has 
been previously validated in the culture of various cell types[31, 32]. Thus it was used in this 
study as a surface coating, to promote cell adhesion and survival.  
The silanization of the cantilever surfaces with DETA was performed using a solution of 
0.1% (v/v) DETA-silane in toluene, heated to 70°C for 30 minutes, followed by a series of 
toluene rinses and reheating to 70°C for 30 minutes in fresh toluene to remove any unreacted 
silane. The surfaces were oven cured at 110°C for 2 hours and stored in a desiccator until use. 
The surface coatings were verified using X-ray photoelectron spectroscopy and contact angle 
goniometry. 
Multiplexed Assay Recording System to Measure Peak Force and Time-to-Fatigue 
 A novel laser and photo-detector system, adapted from Atomic Force Microscopy 
technology, was utilized to calculate peak force (PF) of individual myotube contractions, as well 
as the myotubes’ time-to-fatigue (TTF). Application of this system for similar studies has been 
described in detail previously [60, 86]. Each cantilever chip was transferred to a heated stage 
housed within a modified electrophysiology rig. The culture dish on this heated stage was filled 
with Differentiation Medium (+ 10 mM HEPES) to maintain the cells during analysis.  
Briefly, the automated system consisted of a class 2 photodiode laser positioned below 
the stage so that the beam was focused on the cantilever tip and reflected into the center of a 4-
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quadrant photo-detector[49, 65]. A pulse stimulator was used to elicit contraction in the cultured 
myotubes, and the resulting cantilever deflection was measured in terms of laser displacement (in 
V). The acquired raw data was converted into a direct measurement of force using a modified 
Stoney’s equation as detailed previously[60].  Software was written in labVIEW (National 
Instruments) to control laser and photo-detector positioning to allow scanning across all 
cantilevers on each chip for contractile activity.  
To determine which cantilevers had contracting myotubes, the chip in the culture dish 
was first subjected to broad field electrical stimulation, with pulses of 3 V and 40 ms, delivered 
at a frequency of 1 Hz. The cantilevers were scanned for 5 seconds each to elicit and record 
contractile responses. The active cantilevers were then scanned, with continuous electrical 
stimulation, until their peak force was reduced by half. Thus, the time-to-fatigue was calculated 
by measuring the time elapsed in which a 50% reduction in peak force was observed. 
Immunocytochemistry 
Cells were fixed for 10 minutes in 4% paraformaldehyde solution in PBS.  These cells 
were then subjected to a permeabilization solution consisting of 0.2% Triton-100 in PBS for 30 
minutes followed by incubation in 5% donkey serum plus 0.5% Bovine Serum Albumin in PBS 
(Blocking solution).  The blocking solution was aspirated and replaced with a 1:200 dilution of 
primary antibody against Complex IV (Life technologies 439500) solution in blocking solution 






All experiments were repeated at least 3 times using tissue from different animals on 
cultures from different days. Differences in force and time-to-fatigue measurements among the 
three conditions (“WT”, “SBI-477-Treated”, “PGC-1α KO”) were each evaluated statistically 
using a two-tailed students T-test (α = 0.05). All values are expressed as mean ± standard error. 
Results 
The laser-photodetector system utilized in this study makes use of modified atomic force 
microscopy (AFM) technology, using a laser to measure substrate deflection in response to 
cellular contractile activity. Through application of modified Stoney’s equations, used to 
calculate stress in a thin film, this measurement of deflection can be converted into a direct read-
out of force production in the contracting cells. The high sampling rate of the photodetector 
module (300 – 1000 points per second) far supersedes other published models, which rely on 
video analysis of contractile activity (20 – 30 frames per second), and provides high resolution 
information on contractile waveform for in depth analysis of changes in functional performance. 
The non-invasive nature of this assay provides superiority to the system over and above 
alternative platforms which rely on integration with sensitive force transducers, and enables 
repeat analysis of single cultures over multiple time points in situ. Furthermore, the non-invasive 
nature of this model makes it well suited to incorporation into multi-organ models currently 
under development, where fast access to a particular cell type may be limited by the complexity 
of the platform. 
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Although this system possesses substantial inherent benefit for the reliable and 
reproducible evaluation of cultured contractile cell types, the software and hardware 
configurations installed on this system enable scanning of multiple cantilevers across 
multiplexed arrays. This functionality enables multiple data points to be collected from single 
culture surfaces, providing improved statistical power to observed changes in functional 
performance. Given that most current platforms for investigating skeletal muscle activity in vitro 
rely on multiple myotubes incased in hydrogels, the ability to interrogate single myotubes in 
such systems is lacking. This 2D assay therefore provides a read-out of inter fiber variability for 
more accurate assessment of culture maturation over time, and provides multiple data points per 
condition for more statistically relevant functional analyses. 
The scanning functionality developed by this group is also of substantial importance for 
the continued development of this technology toward higher-throughput applications. The 
experiments detailed in this study utilize cantilever arrays maintained in a single culture well in 
consistent conditions. However, the ability to scan across multiple cantilevers successfully 
provides proof of concept data for the adaptation of this system to support cantilever arrays in 
multiple wells, enabling concurrent investigation of multiple experimental conditions. 
Integration of this technology with a 96 well format or greater would facilitate high-throughput 
investigations of novel drug compound efficacy and toxicity, as well as more informative 
mechanistic studies of pathological conditions and basic scientific research into muscular 
physiology. Adaptation of the chips used in this study to incorporate larger cantilever arrays 
would be relatively simple, and the proof of concept data collected here suggest integration of 
55 
 
the system with a multiwell environment for high-throughput screening would likewise be 
straight-forward. 
Force measurement  
The displacement of the laser position on the photodetector is software converted to a 
“Peak” that is reflection of a change in position of the cantilever tip indicating the maximum 
deflection and maximal stress changes (Figure 15A).  PGC-1α is a regulator of mitochondria 
content and should not affect muscle morphology or the initial peak force output of the 
myotubes.  There was no discernable difference in myotube size or morphology between WT 
(Figure 14A), SBI-477 treated (Figure 14B), and PGC-1α KO (Figure 14C).  Consequently, there 
was no significant difference in initial peak force between WT and experimental groups (Figure 
15C, p>0.31).  The change in peak voltage is evaluated by clampfit software as a measure from 
initiation of the peak to maximum deflection of the cantilever (Figure 15B).   Maximal peak 
force was evaluated for WT, PGC-1α knockout and SBI-477 drug treatment. The peak force was 
measured as 412 +/- 32 nN, 464 +/- 38 nN, and 397 +/- 44 nN respectively (Figure 15C). 
Endurance of Myotubes 
The endurance of myotubes, or time-to-fatigue, has been previously defined and 
established as the time course necessary to observe a 50% reduction in maximum peak force 
output[84] (Figure 16A).  The TTF was calculated as 1134 +/- 36 seconds for WT, 462 +/- 91 
seconds for PGC-1α knockout myotubes and 2610 +/- 300 seconds for SBI-477 drug treated 
cultures.  A significant decline in endurance was observed between WT and PGC-1α knockout 
myotubes (p< .005).  However, when WT myotubes were treated with SBI-477 to upregulate 
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PGC-1 α activity there was observed an over two-fold increase in endurance profiles (Figure 
16B, p< .0002). 
Discussion 
Skeletal muscle is one of many organ systems of importance in drug efficacy and toxicity 
studies.  The scientific community has developed a multitude of assay systems for force 
interrogation in vitro[54, 61, 87].  However, these systems are either limited in their capacity to 
measure endurance, or in their capacity to interrogate single myotube force measurements in real 
time.  Functionally based in vitro systems for the query of skeletal muscle performance provide a 
unique tool in the drug discovery process.  To date, a fully functional in vitro system for the real 
time acquisition of muscle force and fatigue has not been developed.  Through this study we 
have provided a system capable of interrogating the endurance profiles of individual myotubes in 
real time. 
As previously described the analysis of skeletal muscle functionality utilizes a modified 
AFM based multiplexed scanning device and a novel laser scanning system.  At ideal capacity 
this system provides 32 individual points of data collection per cantilever chip.  Each 15” by 15” 
cantilever chip fits into a single well of a standard 12 well plate.  With 32 points of data 
collection per well this provides 384 individual sources of data acquisition.  The novel scanning 
system allows for each cantilever board of a chip to be individually assessed in real time in an 
automated fashion.  These 384 sources of data acquisition per plate provide a 4-fold increase in 
single cell analysis per plate over a standard 96-well assay system. 
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PGC-1α is a co-activator of Peroxisome Proliferator of Activated Receptor-gamma 
(PPAR-γ).  These two in conjunction regulate a multitude of biological pathways including 
mitochondrial content and biogenesis.  In the myotubes derived from PGC-1α KO mice there 
was a significant decrease in mitochondrial content which corresponded to the observed decrease 
in time to fatigue.  This parallels what is found in vivo and in situ[82, 88, 89].  SBI-477 is a novel 
and patent pending agonist for PGC-1α, graciously donated by the Sanford-Burnham medical 
research institute.  After a 24-hour incubation with this compound, myotubes showed an over 2-
fold increase in their fatigability (Figure 16) which is supported by the significant increase in 
mitochondria content compared to the wild-type age matched controls. 
Due to the limited viability of PGC-1α deficient offspring, it was not possible for the 
scope of this study to treat PGC-1α KO myotubes with an agonist to downstream proteins 
regulated by PGC-1α to investigate the recapitulation of WT activity. 
This multiplexed system demonstrates, for the first time, the ability to measure force and 
endurance of protein deficient myotubes in a relatively high throughput manner.  These 
functional endpoints can be manipulated by small molecule application which makes this assay 





Figure 14: Phase contrast images of myotubes on cantilevers.  WT (A), SBI-477 treated (B), and PGC-1α (C) 





Figure 15: Measurement of skeletal muscle force output utilizing AFM based detection system. Graph of raw data 
acquired by the axoscope program in response to cantilever detection from myotube response (A) and a rendering of 
how peak deflection is measured (B). Initial Peak force measurements between WT, PGC-1α KO, and SBI-477 





Figure 16: Endurance profiles of skeletal muscle.  Representative initial peak force traces at time=6 sec and at 50% 
in peak force at time=1204 indicating myotube fatigue.  Graphical representation of time to fatigue data of SBI-477 
treated, WT, and PGC-1α KO myotubes.   A significant upregulation in endurance was seen between SBI-477 





CHAPTER FIVE: GENERAL DISCUSSION 
 One of the limiting factors involved in translating tissue engineering and regenerative 
medicine research to clinical purposes is the poor correlation between basic research and 
application in human subjects.  Some of these limiting factors are due to the cells involved for 
testing and the use of poorly defined animal sera in medium formulations.  Also, the endpoint of 
most in vitro research studies don’t look at actual functionality of tissue.  They are typically 
limited to: 
1. Morphological changes 
2. Alterations in gene transcription or protein expression 
3. Ability for cell survival 
While these endpoints have their value, an up-regulation in certain proteins isn’t 
necessarily commensurate with a functional change.  However, the ability to measure both 
parameters simultaneously helps to establish causality and may provide for a more accurate in 
vitro / in vivo correlation and further application in clinical medicine.  
This dissertation research utilizes basic cell biology and physiology knowledge, 
combined with a previously developed cantilever array system, to further enhance our 
knowledge about basic functional properties of skeletal muscle.  Specifically, the development of 
a new serum-free culture system to derive myotubes from adult satellite cells and investigate 
force and fatigue changes of this muscle in response to chemical and physical stimuli. 
Skeletal muscle tissue engineering constructs are important due to their potential to be 
used in grafts, prosthetic devices, and other bio-hybrid devices for drug discovery.[65, 90]  There 
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are multiple limitations to these grafts, one being the human immune responsible to sera 
containing medium and the incompatability of fetal tissue.  Therefore the development of a 
serum-free culture system of adult based cells eliminates two of these potential pitfalls.  To that 
end, Chapter 2 discusses the formulation of a serum-free medium and the development of a 
culture technique by which functional muscle on the single cell level can be formed from adult 
derived skeletal muscle myoblasts.  The addition of any new culture system and medium 
formulation to the system requires a comparison to previously developed and currently utilized 
methodologies.  The muscle was interrogated for MyHC expression, highly striated sarcomere 
formation, function of ion channels by electrophysiology and shown to be more developed than 
its embryonic or adult sera containing counterparts.  This is a promising advancement in the 
tissue engineering field.  It also creates further excitement in that this formulation is not species 
specific as it is functional for rat (Chapters 2 and 3), mouse (Chapter 4), and primary human 
biopsies (data not shown). 
 The initial goal for the experiments performed in chapter 3 was to utilize the skeletal 
muscle to alter myotube endurance by an exercise regime and to increase force output by the 
addition of creatine.  It has been discovered that subjecting the whole body in vivo to different 
exercise regimes causes a change in the MyHC isoform expression.  Specifically, a chronic low 
frequency regime such as marathon running or long distance walking causes upregulation of type 
I myosin expression. While conversely, a sprinting protocol drives an upregulation of type II 
myosin expression.[63, 91, 92]  Creatine has been shown to help in the upregulation of force 
output and creatine phosphate levels.  We wanted to test these in vivo phenomena in our in vitro 
muscle system.  Incorporating a previously developed  AFM based cantilever system developed 
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by this lab [50, 65] it was possible to measure the effects of chronic low frequency stimulation 
and 40mm creatine treatment on muscle endurance and more importantly fatigue.  To our 
knowledge this is the first in vitro platform to ever measure muscle endurance profiles of WT or 
treated skeletal muscle.  The results were intriguing that both force and endurance were 
upregulated in both treatment regimes. Further investigation pointed to a hypertrophic response 
and upregulation of MyHC expression resulting in increased force and likely an upregulation of 
creatine phosphate was responsible for increased endurance.  CLFS resulted in increased ERR-γ 
levels which are responsible for mitochondrial biogenesis.  Likely the increased force was due to 
a maturation in the overall contractile machinery within the myotube.   
 Lastly, this medium system was used to study the endurance changes that occur as a 
result of a misregulation of a particular protein. Tissue was derived from the hind limbs of adult 
mice deficient in PGC-1α (mice were used for ease and cost purposes).  WT and WT muscle 
treated with an agonist for downstream protein also responsible for mitochondria biogenesis 
were tested as well.  It was demonstrated that we can increase and decrease muscle fatigue 
utilizing small molecule application and protein deficient tissue.  Another novel point is this new 
medium and plating protocol were not limited to WT tissue alone or to specific sources of cells.   
 The development of a new culture protocol utilizing serum-free medium and the ability to 
culture these cells on a bio-MEMs cantilever device for the measurement the force and fatigue 
responses to external stimuli provides a new platform in which to study drug efficacy and in 
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